GRI Bio is trading at 5.99 as of the 14th of March 2025. This is a 0.17% down since the beginning of the trading day. The etf's open price was 6.0. GRI Bio has about a 34 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 14th of December 2024 and ending today, the 14th of March 2025. Click here to learn more.
The investment seeks investment results that correspond generally to the performance, before the funds fees and expenses, of an index called the Cohen Steers Global Realty Majors Index. Cohen Steers is traded on Archipelago Exchange in USA. The company has 525.49 K outstanding shares of which 404.3 K shares are currently shorted by investors with about 2.01 days to cover. More on GRI Bio
GRI Bio [GRI] is traded in USA and was established 2008-05-07. GRI Bio is listed under Biotechnology category by Fama And French industry classification. The fund is classified under Health Care category within Biotechnology family. GRI Bio currently have 2.96 M in assets under management (AUM). , while the total return for the last 3 years was 8.99%.
GRI Bio has about 183.82 M in cash with (9.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.3.
Check GRI Bio Probability Of Bankruptcy
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in GRI Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
GRI Bio financial ratios help investors to determine whether GRI Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GRI with respect to the benefits of owning GRI Bio security.